Dr Reddy's launches lipid controlling drug in USA market

Pharma major Dr Reddy's Laboratories today said it has launched Fenofibrate capsules, a therapeutic equivalent generic version of Antara capsules, in the USA market.

The drug which is indicated to reduce cholesterol and triglycerides (fatty acids) in the blood was approved by the United States Food & Drug Administration (USFDA), DRL said in a statement.

The Antara (fenofibrate) capsules brand and generic had U.S. Sales of approximately $74 Million MAT for the most recent twelve months ending in February 2014 according to IMS Health.

Dr Reddy’s Fenofibrate capsules, USP 43 mg is available in bottle counts of 30, and 130 mg are available in bottle counts of 30 and 90, the drug maker said.

EDITORIAL OF THE DAY

  • Public musn’t pay for domestic servants for our diplomats

    Nothing seems to have changed in the year and half since the fur that flew thick and fast over the case of diplomat Debjani Khobragade and her maid Sa

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Urs Schoettli

Economic integration in east Asia

As trade agreements within a global framework have become increasingly ...

Rajgopal Nidamboor

Up the ante of your conscious existence

It sounds cryptic, but is not as complex as it ...

Gautam Gupta

The ‘fake’ issue needs to be taken seriously

E-commerce players are witnessing unbelievable growth globally. Competition is increasing ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture